aureus infections. Arch Intern Med 2008, 168:805–19.PubMedCrossRef 31. Schmitz FJ, Jones ME: Antibiotics for treatment of infections caused by MRSA and elimination of MRSA carriage. What are the choices? Int J Antimicrob Agents 1997, 9:1–19.PubMedCrossRef 32. Sekiguchi J, Fujino T, Araake M, Toyota E, Kudo K, Saruta K, Yoshikura H, Kuratsuji T, Kirikae T: Wnt inhibitor Emergence of rifampicin resistance in methicillin-resistant Staphylococcus aureus in tuberculosis wards. J Infect Chemother 2006, 12:47–50.PubMedCrossRef 33. Wisplinghoff H, Ewertz B, Wisplinghoff S, Stefanik D, Plum G, Perdreau-Remington F, Seifert H:

Molecular evolution of methicillin-resistant Staphylococcus aureus in the metropolitan area of Cologne, Germany, from 1984 to 1998. J Clin Microbiol 2005, 43:5445–51.PubMedCrossRef 34. Mato R, Campanile F, Stefani S, Crisostomo

MI, Santagati M, Sanches SI, De Lencastre check details H: Clonal types and multidrug resistance patterns of methicillin-resistant Staphylococcus aureus (MRSA) recovered in Italy during the 1990s. Microb Drug Resist 2004, 10:106–13.PubMedCrossRef 35. Kerttula A, Lyytikäinen O, Kardén-Lilja M, Ibrahem S, Salmenlinna S, Virolainen A, Vuopio-Varkila J: Nationwide trends in molecular epidemiology of methicillin-resistant Staphylococcus aureus , Finland, 1997–2004. Torin 1 mw BMC Infectious Diseases 2007, 7:1–9.CrossRef 36. Conceição T, Aires-de-Sousa M, Füzi M, Tóth A, Pászti J, Ungvári E, Van Leeuwen WB, Van Belkum A, Grundmann H, De Lencastre H: Replacement of methicillin-resistant Staphylococcus aureus clones in Hungary over time: a 10-year surveillance study. Clin Microbiol Infect 2007, 13:971–79.PubMedCrossRef 37. Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt BG: The evolutionary history of methicillin-resistant

Staphylococcus aureus (MRSA). Proc Natl Acad Sci 2002, 99:7687–92.PubMedCrossRef 38. Molina A, Del Campo R, Máiz L, Morosini MI, Lamas A, Baquero F, Cantón R: High prevalence in cystic fibrosis patients of multiresistant hospital-acquired methicillin-resistant Staphylococcus aureus ST228-SCCmec I capable of biofilm formation. J Antimicrob Chemother 2008, 62:961–67.PubMedCrossRef Authors’ contributions MD and JL conceived the study and participated in its design. MD, FT, RM, MP and JL participated in field STK38 and clinical aspects of the study. VM and MD carried out the molecular genetic studies and sequence alignment. MD and VM wrote the manuscript which was co-ordinated by JL and critically reviewed by FT, RM and MP. All authors read and approved the final version of the manuscript.”
“Background Leptospira, a slender and flexuous spirochaete with tight coils, contribute to Leptospirosis [1]. The Leptospira genus has been divided into 20 species based on DNA-DNA hybridization studies. Pathogenic species include L. interrogans, L. kirschneri, L. noguchii, L. borgpetersenii, L. weilii, L. santarosai, L. alexanderi and L. alstonii [2–6].